Business
Coherus BioSciences to Report Third Quarter 2021 Financial Results on November 8th
REDWOOD CITY, Calif., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its third quarter 2021
About this update from Coherus Oncology, Inc.
[{"type":"text","content":"REDWOOD CITY, Calif., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its third quarter 2021 financial results will be released after market close on Monday, November 8, 2021. Starting at 5 p.m. ET, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update. After releasing third quarter financial results, the Company will post them on the Coherus website at https://investors.coherus.com. Conference Call Information When: Monday, Nov. 8, 2021, starting at 5 p.m. ETDial -in: (844) 452-6826 (Toll-Free U.S. and Canada) or (765) 507-2587 (International)Conference ID: 1838568 Webcast: https://investors.coherus.com/upcoming-events Please dial-in 15 minutes early to ensure a timely connection to the call. About Coherus BioSciences Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system. For additional information, please visit www.coherus.com. Coherus Contact Information:Cheston TurbyfillCoherus BioSciences, [email protected] \nSource: Coherus BioSciences, Inc.","length":3343,"tagName":"div"}]